University of ChicagoChicago, IL
Disclosures:
3189 - Outcomes of Primary Tumor Stereotactic Ablative Body Radiotherapy for Localized and Metastatic Renal Cell Carcinoma
Tuesday, October 1, 20242:30 PM – 3:45 PM ET